Astec Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2025 ,inter alia, to consider and approve to consider, discuss and decide various matters in connection with the Rights Issue, including the specific terms of the Rights Issue, such as the determination of the Rights Issue price and related payment mechanism, rights entitlement ratio, the record date, timing of the Rights Issue and other terms and conditions with respect to the Rights Issue, subject to the receipt of in-principle approval from the stock exchanges or such other regulatory authorities as may be required